Penn Medicine Provider
Medical Oncology
David J. Vaughn, MD
5.0
(527)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West

About me

  • GU Medical Oncology Professor

Education and training

  • Medical School: Harvard University
  • Residency: NewYork-Presbyterian/Weill Cornell Medical Center
  • Fellowship: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
5.0

530 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
he's a great doctor
May 2025
5.0
5.0
great guy
April 2025
5.0
5.0
excellent care
April 2025
5.0
5.0
he is the best

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: On the medical staff, but does not have privileges to treat patients in the hospital.
Dr. Vaughn is a Penn Medicine physician.

Qualifications and experience

My research

Ugalde-Morales E, Wilf R, Pluta J, Ploner A, Fan M, Damra M, Aben KK, Anson-Cartwright L, Chen C, Cortessis VK, Daneshmand S, Ferlin A, Gamulin M, Gietema JA, Gonzalez-Niera A, Grotmol T, Hamilton RJ, Harland M, Haugen TB, Hauser R, Hildebrandt MAT, Karlsson R, Kiemeney LA, Kim J, Lessel D, Lothe RA, Loveday C, Chanock SJ, McGlynn KA, Meijer C, Nead KT, Nsengimana J, Popovic M, Rafnar T, Richiardi L, Rocca MS, Schwartz SM, Skotheim RI, Stefansson K, Stewart DR, Turnbull C, Vaughn DJ, Winge SB, Zheng T, Monteiro AN, Almstrup K, Kanetsky PA, Nathanson KL, Wiklund F; Testicular Cancer Consortium Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association study , American Journal of Human Genetics , 112(3): 2025,630-643


Cortese BD, Alkhatib KY, Harmatz IM, Michel KF, Lee DJ, Guzzo TJ, Vaughn DJ, Moses KA, Pierorazio PM, Talwar R. The impact of telemedicine on racial and ethnic disparities in oncologic care during the COVID-19 pandemic , Am J Cancer Res, 15: 2025,1224-1233


Kerns SL, Dinh PC Jr, Monahan PO, Stump T, Fung C, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Huddart R, Kollmannsberger C, Martin NE, Nevel K, Kincaid J, Einhorn LH, Travis LB Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer , Journal of the National Cancer Institute : 2025


Dinh PC Jr, Monahan PO, Fung C, Sesso HD, Feldman DR, Vaughn DJ, Hamilton RJ, Huddart R, Martin NE, Kollmannsberger C, Althouse S, Einhorn LH, Frisina R, Root JC, Ahles TA, Travis LB Cognitive function in long-term testicular cancer survivors: impact of modifiable factors , Journal of the National Cancer Institute Cancer Spectrum: 2024


de Wit R, Vaughn DJ, Fradet Y, Fong L, Climent MA, Necchi A, Petrylak DP, Gerritsen WR, Gurney H, Quinn DI, Culine S, Sternberg CN, Bajorin DF, Choueiri TK, Xu J, Imai K, Homet Moreno B, Bellmunt J, Lee JL. Impact of prior chemotherapy on response to second-line pembrolizumab in urothelial cancer: exploratory analysis of the phase 3 KEYNOTE-045 trial , European Urology : 2024


Welch E, Guerraty MA, Demissei BG, Haas N, Takvorian S, Parikh RB, Vaughn DJ, Pryma D, Mankoff DA, Ky B, Narayan V Coronary microvascular dysfunction in men with prostate cancer receiving androgen-deprivation therapy , Clinical Genitourinary Cancer, 22(4): 2024


Hsu M, Shan X, Zhang R, Berlin E, Goel A, Agarwal M, Wong YN, Christodouleas JP, Vaughn DJ, Narayan V, Takvorian SU, Vapiwala N, Pantel AR, Haas NB Prostate cancer recurrence: examining the role of salvage radiotherapy field and risk factors for regional disease recurrence captured on 18F-DCFPyL PET/CT , Clinical Genitourinary Cancer, 22(4): 2024


Demissei BG, Ko K, Huang A, Lee DJ, Doucette AG, Smith AM, Wilcox NS, Reibel J, Sun L, Agarwal M, Haas NB, Hollis G, Shpilsky JE, Takvorian SU, Vaughn DJ, Chen J, Hubbard RA, Powell-Wiley T, Yancy C, Narayan V, Ky B Social determinants of health mediate racial disparities in cardiovascular disease in men With prostate cancer , Journal of the American College of Cardiology Cardio-Oncology , 6: 2024,390-401


Dinh PC, Monahan PO, Fosså SD, Sesso HD, Feldman DR, Dolan ME, Nevel K, Kincaid J, Vaughn DJ, Martin NE, Sanchez VA, Einhorn LH, Frisina R, Fung C, Kroenke K, Travis LB Impact of pain and adverse health outcomes on long-term U.S. testicular cancer survivors , Journal of the National Cancer Institute , 116(3): 2024,455-467


Bührer E, D'Haese D, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A, Hentrich M, Bokemeyer C, Negaard H, Fankhauser C, Shamash J, Vaughn DJ, Sternberg CN, Heidenreich A, Collette L, Gillessen S, Beyer J Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium. , European Journal of Cancer : 2024